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Abstract
 
SLP-65
 
 
 
/
 
 
 
 pre-B cells show a high proliferation rate in vitro. We have shown previously that
 
 
 
5 expression and consequently a conventional pre-B cell receptor (pre-BCR) are essential for
this proliferation. Here, we show that pre-B cells express a novel receptor complex that contains
a 
 
 
 
 heavy chain (
 
 
 
HC) but lacks any surrogate (SL) or conventional light chain (LC). This SL-
deficient pre-BCR (SL
 
 
 
pre-BCR) requires Ig-
 
 
 
 for expression on the cell surface. Anti-
 
 
 
treatment of pre-B cells expressing the SL
 
 
 
pre-BCR induces tyrosine phosphorylation of
 
substrate proteins and a strong calcium (Ca
 
2
 
 
 
) release. Further, the expression of the SL
 
 
 
pre-BCR
is associated with a high differentiation rate toward 
 
 
 
LC-positive cells. Given that B cell devel-
opment is only partially blocked and allelic exclusion is unaffected in SL-deficient mice, we
propose that the SL
 
 
 
pre-BCR is involved in these processes and therefore shares important
functions with the conventional pre-BCR.
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Introduction
 
The development of B cells is a highly regulated process
that can be divided into distinct stages according to the
expression of various surface markers and the recombination
status of the heavy chain (HC) and light chain (LC) genes
(1, 2). The recombination of the HC locus is initiated in
 
pro-B cells (c-kit
 
 
 
B220
 
 
 
CD43
 
 
 
), which represent the earliest
distinguishable B cell population (3). Productive recombi-
nation of the HC locus results in 
 
 
 
HC expression, which
 
pairs with the SL chain and the signaling components Ig-
 
 
 
/
Ig-
 
 
 
 to form the pre-BCR on the cell surface (4, 5). The
SL chain consists of the noncovalently associated VpreB
and 
 
 
 
5 polypeptides that have sequence and presumed
 
structural homology to the Ig V- and C-type domains,
respectively (6). Successful LC recombination and the sub-
sequent association between HC and LC proteins lead to
the expression of the B cell receptor (BCR) complex on
the cell surface and the production of immature B cells that
leave the BM and continue differentiation to become mature
B cells (7, 8). Binding of the BCR to its specific ligand is an
essential requirement for the selection and activation of
immature and mature B cells, respectively (9). Although it
is still unclear whether ligand binding is required for proper
pre-BCR function, recent results indicate that the pre-
BCR can react with ligand molecules on stromal cells (10–12).
Whereas the biological role of this pre-BCR ligand inter-
action is not clear at present, it is established that pre-BCR
expression is crucial for pre-B cell proliferation and differ-
entiation and therefore represents a key checkpoint in B
cell development (13–15). For instance, B cell development is
completely blocked at the pro-B cell stage in mice deficient
for Ig-
 
 
 
 or Ig-
 
 
 
 (16, 17). In 
 
 
 
MT mice that lack the trans-
membrane region of the 
 
 
 
 chain, a complete block of B
cell development and a loss of allelic exclusion were reported
(18, 19). Mice deficient for the SL component 
 
 
 
5, VpreB,
or both showed an incomplete block of B cell development
but intact allelic exclusion (20–22). Since the conventional
pre-BCR cannot be expressed in both the 
 
 
 
MT mice and
the SL-deficient mice, it was suggested that prematurely
expressed LCs allow the expression of the 
 
 
 
HC on the surface
of SL-deficient pre-B cells (23).
Pre-BCR engagement results in activation of protein tyro-
sine kinases (PTKs) of the Src, Syk, and Tec families that
mediate the phosphorylation of substrate proteins (24).
One major substrate of Syk is the adaptor protein SLP-65,
which is also known as BLNK or BASH (25–27). Phos-
phorylated SLP-65 is a central modulator of Ca
 
2
 
 
 
 response
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that couples Syk and the Tec family kinase Btk to phos-
pholipase C (PLC)-
 
 
 
2 (28–30). After phosphorylation by
Syk and Btk, PLC-
 
 
 
2 is activated and generates the second
messenger inositol 1,4,5-trisphosphate which leads to Ca
 
2
 
 
 
release from intracellular stores (31). Mice deficient for
SLP-65 show a partial block of B cell development at the
pre-B cell stage and, due to a defect of receptor down-reg-
ulation pre-B cells from these mice express large amounts
of the pre-BCR on their surface (32–34). Here, we exploit
the increase of 
 
 
 
HC expression on the surface of SLP-65/
 
 
 
5 double mutant (SLP-65/
 
 
 
5
 
 
 
/
 
 
 
) pre-B cells to charac-
terize a novel pre-BCR complex that is expressed without
any surrogate or conventional LCs.
 
Materials and Methods
 
Mice.
 
Ig-
 
 
 
 
 
/
 
 
 
, 
 
 
 
5
 
 
 
/
 
 
 
, and SLP-65
 
 
 
/
 
 
 
 mice were generated as
described previously (17, 20, 32). Single deficient mice were
crossed to generate the SLP-65/
 
 
 
5
 
 
 
/
 
 
 
 and SLP-65/Ig-
 
 
 
 
 
/
 
 
 
 mice.
All animal experiments were performed in compliance with
guidelines of the German law and the MPI for Immunobiology.
 
Cell Purification, Cell Culture, and Cell Lines.
 
Cell suspension
was prepared from the murine BM and cultured in Iscove’s me-
dium containing 10% FCS (Vitromex), 100 U/ml penicillin, 100
U/ml streptomycin (GIBCO BRL), 5 
 
 
 
 10
 
 
 
5
 
 M 2-ME, and IL-7
as described previously (35). The SLP-65/
 
 
 
5
 
 
 
/
 
 
 
 pre-B cell line
mcR2 was established by culturing BM cells in IL-7–supple-
mented medium for extended times (
 
 
 
6 mo). The pre-B cell
lines Dec and Oct were derived from SLP-65
 
 
 
/
 
 
 
 mice and the
pro-B cell line from SLP-65/Ig
 
 
 
 
 
/
 
 
 
 mice.
 
Flow Cytometry.
 
Aliquots of single cell (10
 
6
 
) suspensions from
cell culture was stained for FACS
 
®
 
 analysis (FACSCalibur; Bec-
ton Dickinson) using FITC–, cy5– or biotin–anti-IgM (
 
 
 
 chain
specific; Southern Biotechnology and Dianova), biotin–anti-IgM
 
a
 
(Becton Dickinson), FITC– or biotin–anti-
 
 
 
 (Southern Biotech-
nology), FITC–anti-
 
 
 
 (Southern Biotechnology), and streptavi-
din-cy5 (Dianova). Anti–mouse surrogate LC (SL-156), anti-
VpreB (Vp245), and anti-
 
 
 
5 (LM34) rat mAbs were gifts from
A.G. Rolink (University of Basel, Basel, Switzerland).
 
Retroviral Constructs and Transduction.
 
Retroviral transduc-
tions were performed as described previously (36). pMOWS-
 
 
 
5
vector encoding murine 
 
 
 
5 was used for transfection performed
in the Phoenix™ retroviral producer cell line using GeneJuice™
(Novagen) according to manufacturer’s instructions. For trans-
duction, pre-B cells derived from the BM of SLP-65/
 
 
 
5
 
 
 
/
 
 
 
mice, which were cultured for 2–3 d were mixed with viral su-
pernatants and centrifuged at 1,800 rpm at 37
 
 
 
C for 3 h. Trans-
duction efficiency, measured 1 d later, was between 1 and 10%.
 
Southern Blotting.
 
Genomic DNA was digested with EcoRI at
37
 
 
 
C overnight. 10 
 
 
 
g of DNA was loaded, separated in 0.8%
TAE-agarose gel, and blotted to Nylon membrane (PerkinElmer).
The membrane was hybridized overnight with a P
 
32
 
-labeled probe
corresponding to genomic DNA sequences downstream of JH4 at
the 
 
 
 
 locus as described previously (34). The results were visual-
ized by the development with Hyperfilm™ MP high performance
autoradiography film (Amersham Biosciences).
 
In Vitro Differentiation Assay.
 
BM-derived cells from SLP-
65
 
 
 
/
 
 
 
 and SLP-65/
 
 
 
5
 
 
 
/
 
 
 
 mice were cultured for 1 wk with IL-7
and then divided into two pools, one cultured continuously with
IL-7 and the other without IL-7 for 2 d. The differentiated B cells
were analyzed by FACS
 
®
 
 using anti-
 
 
 
HC and anti-
 
 
 
LC stain.
 
Surface Biotinylation, Immune Purification, and Western Blot Anal-
ysis.
 
SLP-65/Ig-
 
 
 
 
 
/
 
 
 
 pre-B cells, SLP-65/
 
 
 
5
 
 
 
/
 
 
 
 pre-B cells
(mcR2), SLP-65
 
 
 
/
 
 
 
 (Dec) pre-B cells, J558L
 
 
 
M3 (surface 
 
 
 
HC
and 
 
 
 
LC positive), and WEHI-231 (surface 
 
 
 
HC and kLC posi-
tive) were used in biotinylation experiments of surface cellular
proteins. Cells (2 
 
 
 
 10
 
7
 
) were washed twice with ice cold PBS.
The cell pellets were resuspended in EZ-Link™ Sulfo-NHS-Bio-
tin (Pierce Chemical Co.) at 1 
 
 
 
g/ml in PBS and incubated on
ice for 30 min. After PBS washing, the cell pellets were lysed in
ice cold digitonin lysis buffer (50 mM Tris-HCl, pH 7.4; 0.5%
digitonin [Sigma-Aldrich], 137.5 mM NaCl, 1% glycerol, 1 mM
Na-orthovanadate, 0.5 mM EDTA, pH 8, and protease inhibitor
cocktail [Sigma-Aldrich]) and kept on ice for 15 min. After 15
min centrifugation at 14,000 rpm and 4
 
 
 
C, the supernatant was
collected. 
 
 
 
HC and 
 
 
 
HC-associated proteins were immune pu-
rified from the supernatant by incubation with goat anti–mouse
IgM (
 
 
 
 chain specific; Southern Biotechnology) plus protein G
sepharose beads (Amersham Biosciences) at 4
 
 
 
C overnight. Puri-
fied proteins were washed with PBS or lysis buffer, subjected to
12% SDS-PAGE, and blotted to Immobilon™ PVDF transfer
membrane (Millipore). The biotinylated proteins were revealed
by streptavidin-HRPO (Pierce Chemical Co.) following ECL
developmental system™ (Amersham Biosciences) according to
manufacturer’s instructions. 
 
 
 
HC, 
 
 
 
LC, and 
 
 
 
LC were detected
with the same antibodies used for FACS
 
®
 
 analysis. Ig-  was de-
tected with rabbit polyclonal antibody (a gift from J.C. Cambier,
Integrated Department of Immunology, Jewish Medical and Re-
search Center, and University of Colorado Health Sciences Cen-
ter, Denver, CO).
Cell Stimulation. Cell pellets were incubated with 20  g/ml
of goat anti–mouse IgM or goat anti–mouse kappa (Southern Bio-
technology) at 37 C for 2 min. Stimulation was stopped by the ad-
dition of ice cold PBS, and after centrifugation the cell pellets
were lysed in ice cold lysis buffer (50 mM Tris-HCl, pH 7,4); 1%
n-octyl- -d-glucopyranosid [Applichem], 137.5 mM NaCl, 1%
glycerol, 1 mM Na-orthovanadate, 0.5 mM EDTA, pH 8, supple-
mented with protease inhibitor cocktail as described above). Tyro-
sine-phosphorylated cellular proteins were immune purified from
the total cellular lysates by incubation with antiphosphotyrosine
antibody 4G10 (Upstate Biotechnology) at 4 C overnight. The
purified proteins were subjected to 10% SDS-PAGE, revealed by
antiphosphotyrosine antibody (4G10, Upstate Biotechnology) fol-
lowed by HRPO-labeled anti–mouse antibody (Pierce Chemical
Co.) and developed as described above.
Ca2  Mobilization. Cells (5   106) resuspended in Iscove’s
medium containing 1% FCS were incubated with 5  g/ml of
Indo-1 a.m. (Molecular Probes) and 0.5  g/ml of pluronic F-127
(Molecular Probes) at 37 C for 45 min. The cell pellets were then
resuspended in Iscove’s medium (containing 1% FCS) and kept
on ice. Ca2  response was induced by the addition of goat anti–
mouse IgM (Southern Biotechnology) at a final concentration of
20  g/ml or anti–mouse kappa (Southern Biotechnology) at the
same concentration as a control.
Results
SLP-65/ 5 /  Pre-B Cells Express a Novel  -Containing
Receptor. BM-derived SLP-65 /  pre-B cell cultures re-
peatedly contained cell populations that were positive for
 HC but negative for conventional LCs and the antibody
SL-156 recognizing  5 in association with   (not de-
picted). We postulated that  HC might be expressed onSu et al. 1701
the surface of pre-B cells in the absence of  5. To test this
hypothesis, we analyzed in parallel BM-derived pre-B cells
from WT, SLP-65 / ,  5 / , and SLP-65/ 5 /  litter-
mates by FACS®. At day 4 of in vitro culture, the cells
were stained with SL-156, anti- / , and anti- HC. No
evident pre-BCR expression ( HC /SL-156 ) was de-
tected in the WT pre-B cell culture, and most  HC  WT
cells were also  /   (Fig. 1 A, top). However, the SLP-
65 /  pre-B cell culture contained a clear  HC /SL-
156  pre-B cell population (74%) in contrast to the WT,
 5 / , and SLP-65/ 5 /  cultures (Fig. 1 A, left). In ad-
dition,  20% of the SLP-65 /  pre-B cells were  HC /
SL-156 /  /  , indicating that they express the SL pre-
BCR that lacks a conventional or a surrogate LC (Fig. 1
A, second left and right panels). The  HC /SL-156  cells
in the pre-B cell cultures from  5 /  and SLP-65/ 5 / 
mice consisted of two distinct populations. A minor popu-
lation that expressed the  HC as a part of the BCR to-
gether with a conventional LC (  or  ) and a major popu-
lation expressing the  HC as a part of the SL pre-BCR.
The ratio of the SL pre-BCR–expressing cells and its
amount on each cell are increased in SLP-65/ 5 /  com-
pared with  5 /  pre-B cell cultures (Fig. 1 A, bottom
four panels).
To confirm that the  HC of the SL pre-BCR is ex-
pressed on the surface as a subunit of a receptor complex,
we generated mice deficient for SLP-65 and the signal
transduction subunit Ig-  (SLP-65/Ig-  /  mice). BM-
derived pre-B cells from these mice showed no  HC ex-
pression on the cell surface (Fig. 1 B). To show that the
SL pre-BCR can also be detected in cells that have not
been cultured in vitro, we analyzed freshly isolated BM
cells from SLP-65/ 5 /  and SLP-65/Ig-  /  mice by
FACS®. These experiments showed that a distinct B cell
fraction (6%) in the BM of SLP-65/ 5 /  but not of SLP-
65/Ig-  /  mice expressed the SL pre-BCR (Fig. 1 C).
Figure 1. Pre-B cells with a  -containing, LC-
deficient receptor. (A) FACS® analysis of MACS-
purified CD19  BM cells from littermates of the indi-
cated genotypes. The cells were cultured in IL-7 for
4 d and stained for conventional pre-BCR (  versus
SL-156) or BCR (  versus kappa/lambda). (B) FACS®
analysis of SLP-65/Ig-  /  BM-derived pre-B cells
showing that the SL pre-BCR requires Ig-  for ex-
pression on the cell surface. (C) FACS® analysis of
gated B cells freshly isolated from the BM of the indi-
cated mice showing that the SL pre-BCR can be
detected in SLP-65/ 5 /  pre-B cells that have not
been cultured. Numbers refer to the percentage of
cells in each gate.
Figure 2.  5 expression results in pre-B
cell proliferation. (A) FACS® analysis of the
indicated BM-derived pre-B cells showing
that no VpreB expression is detected on
SLP-65/ 5 /  cells. Reconstitution of  5
expression with a retroviral vector (ts 5)
resulted in surface VpreB expression and
expansion of the transduced cells. The BM-
derived cells were transduced at day 2 of in
vitro culture and analyzed 18 d after trans-
duction. Numbers refer to the percentage of
cells in each quadrant. (B) Southern blot
analysis of genomic DNAs showing the
polyclonality of BM-derived SLP-65/ 5 / 
pre-B cells. The genomic DNA was extracted
from BM-derived pre-B cells of WT, SLP-65 / , and SLP-65/ 5 /  mice cultured for 1 wk (lanes 1–3). Genomic DNA from the clonal SLP-65 / 
pre-B cell line (Oct) was used as a control (lane 4). The DNA was digested with EcoRI separated by 0.8% agarose gel. After blotting, the membrane was
hybridized with a JH probe (as described in Materials and Methods). GL indicates germ line configuration.A Novel Pre-BCR Complex on SLP-65/ 5 /  Pre-B cells 1702
The SL component VpreB might associate with  HC in
the absence of  5 and allow surface expression of an incom-
plete pre-BCR (37). To exclude this possibility, we per-
formed FACS® analysis with anti-VpreB and show that
VpreB is not associated with  HC in the SL pre-BCR on
the surface of SLP-65/ 5 /  pre-B cells (Fig. 2 A, second
panel). However, surface VpreB expression was easily de-
tected when  5 was retrovirally transduced into SLP-65/
 5 /  pre-B cells, and the ratio of the transduced cells in-
creased from 9% at day 4 to 46% at day 18 posttransduction
(Fig. 2 A, third panel and not depicted). Further, we ana-
lyzed the Ig HC rearrangement status in genomic DNA
from WT, SLP-65 / , and SLP-65/ 5 /  pre-B cell cul-
tures. This analysis showed that similar to WT and SLP-
65 /  the DNA from SLP-65/ 5 /  pre-B cells contained
several submolar JH-rearranged bands, indicating that the
cells were polyclonal and excluding the possibility that few
clones with abnormal  H chains gave rise to surface  HC
expression (Fig. 2 B). In summary, SLP-65/ 5 /  and  5 / 
pre-B cells express a SL pre-BCR that cannot provide the
cells with a strong selective advantage to dominate the cul-
ture, since a considerable proportion of these pre-B cells is
 HC  in contrast to SLP-65 /  pre-B cells that are mostly
 HC  (Fig. 1 A). Further, the reconstitution of pre-BCR
(i.e.,  5) expression in SLP-65/ 5 /  pre-B cells resulted in
the proliferative selection of  HC  cells (Fig. 2 A).
Figure 3. The SL pre-BCR is associated
with enhanced differentiation. BM-derived
pre-B cells from a 1-wk culture were incu-
bated for 2 d in the absence or presence of
IL-7 (top and bottom, respectively). Unsorted
and   HC  (   ) and  HC  (   ) sorted
cells were analyzed in parallel. Sorted
 HC  SLP-65 /  pre-B cells showed poor
survival and therefore were not included.
 HC versus  LC FACS® profiles of the in-
dicated genotypes are shown. Numbers refer
to the percentage of cells in each quadrant.
Figure 4. Pre-B cell lines that express the
SL pre-BCR. (A) FACS® analysis of the
SLP-65 /  (Dec) or SLP-65/ 5 /  (mcR2)
pre-B cell lines stained for conventional pre-
BCR (  versus VpreB, top;   versus  5,
bottom). (B) FACS® analysis of Dec and
mcR2 pre-B cells cultured with IL-7 (top)
or without IL-7 for 2 d (middle and bottom).
Cells were stained with antibody DS-1 for
the  HCa allotype that detects conventional
pre-BCR (Dec) but not the SL pre-BCR
(mcR2) (  versus  a, top). After IL-7 re-
moval, differentiation and  LC expression
enable the recognition of the  HCa allotype
in the mcR2 cells (middle and bottom).
Numbers refer to the percentage of cells in
the gate. (C) Western blot analysis of protein
complexes obtained with anti-  immune
purification. The surface cellular proteins of
the indicated cell lines were biotinylated
before cell lysis. The purified protein com-
plexes were separated by SDS gel electro-
phoresis. After blotting, the membrane was
incubated with streptavidin-HRPO (tol) and
subsequently with antibodies recognizing
 HC,   LC,   LC, VpreB, or Ig- . The
pro-B  cell line was established from BM
cells of an SLP-65/Ig-  /  mouse by ex-
tended culture in IL-7. The cell lines
J558L M3 and WEHI-231 were used as
controls for cells expressing a BCR with
 LC and  LC, respectively. (D) Western
blot analysis of total cellular lysates for  HC
expression in the indicated cell lines.Su et al. 1703
The SL pre-BCR Is Associated with Enhanced Differentiation
In Vitro. We further tested the ability of SLP-65/ 5 / 
pre-B cells to differentiate in vitro. 2 d after withdrawal of
IL-7 to induce differentiation, we observed  LC recombi-
nation and the appearance of similar amounts of BCR  cells
in SLP-65 /  and SLP-65/ 5 /  cultures (Fig. 3, panels 1–2).
To show that pre-B cells with a surface SL pre-BCR are
not blocked in development, we compared the in vitro
differentiation of sorted  HC  pre-B cells from SLP-65/
 5 /  and SLP-65 /  cultures. After 2 d of IL-7 removal,
30 and 19% of the SLP-65/ 5 /  and SLP-65 /  pre-B
cells differentiated to BCR  cells, respectively (Fig. 3, pan-
els 3–4). In contrast, the SLP-65/ 5 /  pre-B cells that did
not express an SL pre-BCR showed a poor differentiation
capacity (Fig. 3, panel 5). This indicates that the SL pre-
BCR is capable of inducing differentiation and that the
 HC of this receptor can pair with  LC. Sorted  HC 
pre-B cells from SLP-65 /  cultures did not grow in cul-
ture and therefore were not analyzed.
Pre-B Cell Lines Expressing the SL pre-BCR. Prolonged
in vitro culture of BM-derived SLP-65/ 5 /  pre-B cells
allowed the generation of cell lines that express the
SL pre-BCR. Analysis of five independent lines showed a
similar pattern of surface marker expression compared with
short-term cultures and were CD19 /CD43 /CD25 /
 HC /VpreB / 5  (Fig. 4 A and not depicted). Interest-
ingly, the DS-1 antibody, which is specific for the IgHCa
allotype present in SLP-65/ 5 /  mice, did not detect the
 HC on these cell lines (mcR2) and on cells from short-
term culture (Fig. 4 B, top, and not depicted). Given that
the DS-1 antibody detects only  HC associated with an SL
or conventional LC but not free  HC (38), we conclude
that the SL pre-BCR contains a  HC without any light
chain. To prove that the  HC of the SLP-65/ 5 /  cells is
recognizable by DS-1 after association with a light chain,
IL-7 was removed for 2 d from the culture to induce  LC
recombination. Indeed, all SLP-65/ 5 /  cells with a sur-
face  LC were readily detected with DS-1 (Fig. 4 B, bot-
tom). Similar to the results of sorted  HC  cells (Fig. 3),
the SLP-65/ 5 /  pre-B cells showed a higher differentia-
tion capacity compared with SLP-65 /  pre-B cells. We
used the SLP-65/ 5 /  pre-B cell lines to further charac-
terize the SL pre-BCR. Western blot analysis revealed that
the SLP-65/ 5 /  pre-B cells mainly contain a complete
 HC and not the truncated D  protein (Fig. 4 D). Bio-
tinylation of surface proteins followed by anti-  immune
purification and streptavidin Western blot analysis con-
firmed the FACS® data that  HC is expressed on the sur-
face of SLP-65/ 5 /  pre-B cells (Fig. 4 C, top). Further,
the  HC of both the pre-BCR and the SL pre-BCR was
associated with Ig- , whereas VpreB was only detected in
the context of the pre-BCR (Fig. 4 C, bottom). In these
surface biotinylation experiments, no  HC-associated pro-
teins were detected that might correspond to a light chain
or similar molecules (not depicted).
Engagement of the SL pre-BCR Induces a Massive Ca2 
Response. To analyze the signaling competence of the
SL pre-BCR, we compared the phosphorylation of PTK
substrate proteins after anti-  treatment of SLP-65 /  and
SLP-65/ 5 /  short-term cultures and pre-B cell lines. In
all cell types, anti-  treatment induced tyrosine phosphory-
lation of similar substrate proteins including PLC- 2, Syk,
Ig- , and the adaptor protein LAT (linker for activation of
T cells) (Fig. 5 A). This confirms our recent results showing
that LAT is expressed in pre-B cells and phosphorylated
upon pre-BCR engagement (35). The induction of sub-
strate tyrosine phosphorylation was lower in the short-term
cultures compared with the cell lines (Fig. 5 A, lanes 1–6
and 7–12). Further, the SLP-65/ 5 /  pre-B cells showed
the highest induction of tyrosine phosphorylation (Fig. 5
A, lane 11). Compared with the short-term culture of SLP-
65 /  pre-B cells and the SLP-65 /  pre-B cell line Dec,
Figure 5. Engagement of the SL pre-BCR induces PTK substrate phosphorylation and a massive Ca2  release. (A) Antiphosphotyrosine Western blot
analysis of proteins purified by antiphosphotyrosine precipitation. BM-derived cells from SLP-65 /  and SLP-65/ 5 /  mice cultured for 1 wk (lanes 1–6),
pre-B cell lines Dec (lane 7–9) and mcR2 (lanes 10–12) were left unstimulated (lanes 1, 4, 7, and 10), stimulated with 20  g/ml anti-  (lanes 2, 5, 8 and
11) or 20  g/ml anti-kappa (lanes 3, 6, 9 and 12) at 37 C for 2 min. For all lanes, 1   107 cell equivalents were loaded. (B) BM-derived pre-B cells and
cell lines (described in A) were loaded with Indo-1 and treated with anti-  (left and right lanes) to induce Ca2  response. Antikappa treatment was used
as a negative control (middle lane).A Novel Pre-BCR Complex on SLP-65/ 5 /  Pre-B cells 1704
anti-  treatment of the SLP-65/ 5 /  short-term culture
and the pre-B cell line mcR2 induced a strong Ca2  re-
sponse (Fig. 5 B). Treatment with anti-  as a control in-
duced neither phosphorylation nor Ca2  release (Fig. 5, A
and B, middle). These results demonstrate a profound dif-
ference between the SL pre-BCR and the conventional
pre-BCR in the induction of Ca2  release.
Discussion
Our experiments demonstrate that the  HC forms an
Ig- –associated and signaling-competent complex on the
surface of pre-B cells that lack any SL or conventional light
chains. These cells can be detected in the BM of SLP-65/
 5 /  mice and can be grown in vitro in IL-7–supple-
mented medium. The SL pre-BCR on the surface of SLP-
65/ 5 /  pre-B cells contains a complete  HC of the
same molecular weight as the  HC from control cell lines,
so that it is unlikely that deletions within the variable re-
gion or the CH1 domain of  HC lead to SL pre-BCR
expression in the absence of SL or conventional light
chains. Previous reports showed that some human  H
chains with special VH genes could be expressed on the
cell surface in the absence of SL or conventional LC (39).
These aberrant  H chains induced apoptosis and were only
found in pro-B cells, but not in preB or mature B cells, in-
dicating that pro-B cells with this  HC are negatively se-
lected. For several reasons, we assume that a functional
rather than an aberrant  HC is expressed in the SLP-65/
 5 /  pre-B cells. First, SLP-65/ 5 /  pre-B cells are
polyclonal, arguing against the use of highly selected VH
genes able to generate  HC with LC-independent expres-
sion on the cell surface. Second, no increased apoptosis was
detected when  HC  SLP-65/ 5 /  pre-B cells were
sorted and analyzed for differentiation. Third, the  HC 
SLP-65/ 5 /  pre-B cells differentiated readily to imma-
ture B cells, whereas  HC  SLP-65/ 5 /  cells showed a
poor differentiation capacity, demonstrating that the  H
chains do not block but rather promote development. It is
unlikely that the  H chains of the sorted  HC  SLP-65/
 5 /  pre-B cells are replaced during differentiation, since
this would suggest that replacement in the  HC  cells is
more frequent than de novo recombination in  HC  cells.
We reported previously that SLP-65 /  pre-B cells
show an increased proliferation capacity that can lead to
pre-B cells tumors (33, 34). Since the SLP-65/ 5 /  pre-B
cells showed a decreased proliferation capacity compared
with SLP-65 /  pre-B cells, we concluded that the high
proliferation rate of SLP-65 /  pre-B cells in vitro re-
quired the expression of the conventional pre-BCR (33).
In the present study, we show that reconstitution of  5
expression in SLP-65/ 5 /  pre-B cells lead to the en-
richment of cells with a conventional pre-BCR. Thus, the
SL pre-BCR on SLP-65/ 5 /  pre-B cells does not
seem to induce cell proliferation. In full agreement with
this, no pre-B cell tumors were observed in SLP-65/ 5 / 
mice ( 500).
We have shown recently that the adaptor protein LAT is
involved in pre-BCR signaling and in the rescue of SLP-
65 /  pre-B cells (35). SLP-65/ 5 /  pre-B cells express
high amounts of LAT, which explains their capability to
mobilize Ca2  in the absence of SLP-65. However, it is
currently unclear why receptor engagement induces a
strong Ca2  response in SLP-65/ 5 /  pre-B cells com-
pared with SLP-65 /  pre-B cells.
In a recent study, Ohnishi and Melchers (40) demon-
strated that mutations in the non-Ig portion of  5 lead to
increased pre-BCR accumulation on the cell surface, sug-
gesting that  5 controls the internalization of the pre-
BCR. Further, they showed that the same  5 mutations
abolished the constitutive, cell autonomous signaling ca-
pacity of the pre-BCR. However, the signaling capacity of
these mutant pre-BCR molecules was restored after cross-
linking with anti- , suggesting that  5 is involved in the
cross-linking of the pre-BCR on the surface of pre-B cells
(40). These results indicate that, in the uninduced situation,
the SL pre-BCR may be less efficiently cross-linked and
internalized than the conventional pre-BCR and that
cross-linking of the pre-BCR is required for the prolifera-
tion but not the differentiation of pre-B cells.
However, in BM-derived pre-B cells from WT mice we
could not detect conventional pre-BCR or SL pre-BCR–
expressing cells, and most  HC  cells in these cultures
were also  LC , indicating that they were immature B
cells. We assume that defective receptor internalization due
to a deficiency in SLP-65,  5, or both simply allows the
detection rather than the formation of both the conven-
tional pre-BCR and the SL pre-BCR.
Although the exact role and significance of the SL pre-
BCR are not fully clear, this receptor may explain previous
results. For instance, B cell development is only partially
blocked in  5 /  mice, which is in contrast to the com-
plete developmental block in  MT mice lacking the trans-
membrane region of  HC (18). In both cases, no ex-
pression of a conventional pre-BCR and a block in
differentiation are expected. However, the  5 /  pre-B
cells bypass this block, indicating that the  HC forms alter-
native complexes in the absence of an SL. According to
previous reports, prematurely expressed conventional light
chains could pair with  HC and compensate the loss of the
SL chain in  5 /  pre-B cells (23). However, this rescue of
SL deficiency required an early onset of  LC expression,
which might be unlikely because kLC expression is largely
restricted to cells at later stages of B cell development (23).
We propose that in  5 /  pre-B cells, an SL pre-BCR
may induce differentiation of these cells and explain the
difference between the  5 /  and  MT mice. In addition,
the fact that the  HC forms an SL pre-BCR on pre-B
cells may also explain why allelic exclusion still operates in
SL chain deficient but not in  MT mice (19, 22).
Normally, a  HC unpaired with an SL or a conventional
LC is retained in the ER by the chaperone BiP (41). BiP
binds to the unpaired CH1 domain of  HC and retains it
in the ER until an SL or a conventional LC displaces BiPSu et al. 1705
and allows the transport of the completely assembled recep-
tor to the cell surface. Our experiments with surface bio-
tinylation did not detect additional proteins that might asso-
ciate with  HC and allow its dissociation from BiP. The
staining experiments with the  HC-allotype–specific anti-
body (DS-1), which recognizes  HCa only when it is asso-
ciated with an SL or a conventional LC, suggest that  HC
is expressed on the surface without associated proteins. It is
currently unclear how the  HC can circumvent the BiP
retention control in SLP-65/ 5 /  pre-B cells. A better
understanding of the SL pre-BCR should help to clarify
the requirements for surface  HC expression, allelic exclu-
sion, pre-B cell proliferation, and differentiation.
We thank Peter J. Nielsen for discussions; Andreas Wuerch and
Hubertus Kohler for Ca2  measurement; and Cathrin Eschbach and
Ingrid Fidler for technical help.
This work was supported by a grant from the Ministry of Sci-
ence, Research and Arts of Baden-Württemberg to M. Reth and
by the Deutsche Forschungsgemeinschaft (SFB 620).
Submitted: 20 August 2003
Accepted: 15 October 2003
References
1. Osmond, D.G., A. Rolink, and F. Melchers. 1998. Murine B
lymphopoiesis: towards a unified model. Immunol. Today. 19:
65–68.
2. Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and
K. Hayakawa. 1991. Resolution and characterization of pro-B
and pre-pro-B cell stages in normal mouse bone marrow. J.
Exp. Med. 173:1213–1225.
3. Benschop, R.J., and J.C. Cambier. 1999. B cell development:
signal transduction by antigen receptors and their surrogates.
Curr. Opin. Immunol. 11:143–151.
4. Tenboekel, E., F. Melchers, and A.G. Rolink. 1998. Precur-
sor B cells showing H chain allelic inclusion display allelic ex-
clusion at the level of pre-B cell receptor surface expression.
Immunity. 8:199–207.
5. Karasuyama, H., A. Rolink, Y. Shinkai, F. Young, F.W. Alt,
and F. Melchers. 1994. The expression of Vpre-B/lambda 5
surrogate light chain in early bone marrow precursor B cells
of normal and B cell-deficient mutant mice. Cell. 77:133–
143.
6. Burrows, P.D., R.P. Stephan, Y.H. Wang, K. Lassoued,
Z.X. Zhang, and M.D. Cooper. 2002. The transient expres-
sion of pre-B cell receptors governs B cell development.
Semin. Immunol. 14:343–349.
7. Rajewsky, K. 1996. Clonal selection and learning in the anti-
body system. Nature. 381:751–758.
8. Rolink, A.G., F. Melchers, and J. Andersson. 1999. The
transition from immature to mature B cells. Curr. Top. Micro-
biol. Immunol. 246:39–43.
9. Pike, K.A., and M.J.H. Ratcliffe. 2002. Cell surface immu-
noglobulin receptors in B cell development. Semin. Immunol.
14:351–358.
10. Gauthier, L., B. Rossi, F. Roux, E. Termine, and C. Schiff.
2002. Galectin-1 is a stromal cell ligand of the pre-B cell re-
ceptor (BCR) implicated in synapse formation between pre-B
and stromal cells and in pre-BCR triggering. Proc. Natl. Acad.
Sci. USA. 99:13014–13019.
11. Bradl, H., and H.M. Jack. 2001. Surrogate light chain-medi-
ated interaction of a soluble pre-B cell receptor with adherent
cell lines. J. Immunol. 167:6403–6411.
12. Rolink, A.G., T. Winkler, F. Melchers, and J. Andersson.
2000. Precursor B cell receptor–dependent B cell prolifera-
tion and differentiation does not require the bone marrow or
fetal liver environment. J. Exp. Med. 191:23–31.
13. Martensson, I.L., A. Rolink, F. Melchers, C. Mundt, S. Li-
cence, and T. Shimizu. 2002. The pre-B cell receptor and its
role in proliferation and Ig heavy chain allelic exclusion.
Semin. Immunol. 14:335–342.
14. Conley, M.E., J. Rohrer, L. Rapalus, E.C. Boylin, and Y.
Minegishi. 2000. Defects in early B-cell development: com-
paring the consequences of abnormalities in pre-BCR signal-
ing in the human and the mouse. Immunol. Rev. 178:75–90.
15. Melchers, F., E. ten Boekel, T. Seidl, X.C. Kong, T. Yama-
gami, K. Onishi, T. Shimizu, A.G. Rolink, and J. Andersson.
2000. Repertoire selection by pre-B-cell receptors and B-cell
receptors, and genetic control of B-cell development from
immature to mature B cells. Immunol. Rev. 175:33–46.
16. Gong, S., and M.C. Nussenzweig. 1996. Regulation of an
early developmental checkpoint in the B cell pathway by Ig
beta. Science. 272:411–414.
17. Pelanda, R., U. Braun, E. Hobeika, M.C. Nussenzweig, and
M. Reth. 2002. B cell progenitors are arrested in maturation
but have intact VDJ recombination in the absence of Ig-alpha
and Ig-beta. J. Immunol. 169:865–872.
18. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A
B cell-deficient mouse by targeted disruption of the mem-
brane exon of the immunoglobulin mu chain gene. Nature.
350:423–426.
19. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of
mu chain membrane exon causes loss of heavy-chain allelic
exclusion. Nature. 356:154–156.
20. Kitamura, D., A. Kudo, S. Schaal, W. Muller, F. Melchers,
and K. Rajewsky. 1992. A critical role of lambda 5 protein in
B cell development. Cell. 69:823–831.
21. Mundt, C., S. Licence, T. Shimizu, F. Melchers, and I.L.
Martensson. 2001. Loss of precursor B cell expansion but not
allelic exclusion in VpreB1/VpreB2 double-deficient mice. J.
Exp. Med. 193:435–445.
22. Shimizu, T., C. Mundt, S. Licence, F. Melchers, and I.L.
Martensson. 2002. VpreB1/VpreB2/lambda 5 triple-deficient
mice show impaired B cell development but functional allelic
exclusion of the IgH locus. J. Immunol. 168:6286–6293.
23. Pelanda, R., S. Schaal, R.M. Torres, and K. Rajewsky. 1996.
A prematurely expressed Ig-kappa transgene, but not a
V-kappa-J-kappa gene segment targeted into the Ig-kappa
locus, can rescue B cell development in lambda-5-deficient
mice. Immunity. 5:229–239.
24. Tamir, I., and J.C. Cambier. 1998. Antigen receptor signal-
ing—integration of protein tyrosine kinase functions. Onco-
gene. 17:1353–1364.
25. Wienands, J., J. Schweikert, B. Wollscheid, H. Jumaa, P.J.
Nielsen, and M. Reth. 1998. SLP-65: a new signaling com-
ponent in B lymphocytes which requires expression of the
antigen receptor for phosphorylation. J. Exp. Med. 188:791–
795.
26. Fu, C., C.W. Turck, T. Kurosaki, and A.C. Chan. 1998.
BLNK—a central linker protein in B cell activation. Immu-
nity. 9:93–103.
27. Goitsuka, R., Y. Fujimura, H. Mamada, A. Umeda, T.
Morimura, K. Uetsuka, K. Doi, S. Tsuji, and D. Kitamura.A Novel Pre-BCR Complex on SLP-65/ 5 /  Pre-B cells 1706
1998. BASH, a novel signaling molecule preferentially ex-
pressed in B cells of the bursa of Fabricius. J. Immunol. 161:
5804–5808.
28. Ishiai, M., M. Kurosaki, R. Pappu, K. Okawa, I. Ronko, C.
Fu, M. Shibata, A. Iwamatsu, A.C. Chan, and T. Kurosaki.
1999. BLNK required for coupling Syk to PLC gamma 2 and
Rac1-JNK in B cells. Immunity. 10:117–125.
29. Su, Y.W., Y. Zhang, J. Schweikert, G.A. Koretzky, M.
Reth, and J. Wienands. 1999. Interaction of SLP adaptors
with the SH2 domain of Tec family kinases. Eur. J. Immunol.
29:3702–3711.
30. Hashimoto, S., A. Iwamatsu, M. Ishiai, K. Okawa, T. Yama-
dori, M. Matsushita, Y. Baba, T. Kishimoto, T. Kurosaki,
and S. Tsukada. 1999. Identification of the SH2 domain
binding protein of Bruton’s tyrosine kinase as BLNK—func-
tional significance of Btk-SH2 domain in B-cell antigen re-
ceptor-coupled calcium signaling. Blood. 94:2357–2364.
31. Kurosaki, T., A. Maeda, M. Ishiai, A. Hashimoto, K. Inabe,
and M. Takata. 2000. Regulation of the phospholipase
C-gamma 2 pathway in B cells. Immunol. Rev. 176:19–29.
32. Jumaa, H., B. Wollscheid, M. Mitterer, J. Wienands, M.
Reth, and P.J. Nielsen. 1999. Abnormal development and
function of B lymphocytes in mice deficient for the signaling
adaptor protein SLP-65. Immunity. 11:547–554.
33. Flemming, A., T. Brummer, M. Reth, and H. Jumaa. 2003.
The adaptor protein SLP-65 acts as a tumor suppressor that
limits pre-B cell expansion. Nat. Immunol. 4:38–43.
34. Jumaa, H., L. Bossaller, K. Portugal, B. Storch, M. Lotz, A.
Flemming, M. Schrappe, V. Postila, P. Riikonen, J.
Pelkonen, et al. 2003. Deficiency of the adaptor SLP-65 in
pre-B-cell acute lymphoblastic leukaemia. Nature. 423:452–
456.
35. Su, Y.-w., and H. Jumaa. 2003. LAT links the pre-BCR to
calcium signaling. Immunity. 19:295–305.
36. Ketteler, R., S. Glaser, O. Sandra, U.M. Martens, and U.
Klingmuller. 2002. Enhanced transgene expression in primi-
tive hematopoietic progenitor cells and embryonic stem cells
efficiently transduced by optimized retroviral hybrid vectors.
Gene Ther. 9:477–487.
37. Seidl, T., A. Rolink, and F. Melchers. 2001. The VpreB pro-
tein of the surrogate light-chain can pair with some mu
heavy-chains in the absence of the lambda 5 protein. Eur. J.
Immunol. 31:1999–2006.
38. Stall, A.M. 1996. Mouse immuoglobulin allotypes. In Weir’s
Handbook of Experimental Immunology. 5th edition. L.A.
Herzenberg, D.M. Weir, L.A. Herzenberg, and C. Blackwell,
editors. Blackwell Science Publishers, Boston, MA. 1–16.
39. Minegishi, Y., and M.E. Conley. 2001. Negative selection at
the pre-BCR checkpoint elicited by human mu heavy chains
with unusual CDR3 regions. Immunity. 14:631–641.
40. Ohnishi, K., and F. Melchers. 2003. The nonimmunoglobu-
lin portion of  5 mediates cell-autonomous pre-B cell recep-
tor signaling. Nat. Immunol. 4:849–856.
41. Haas, I.G., and M. Wabl. 1983. Immunoglobulin heavy
chain binding protein. Nature. 306:387–389.